Zymergen raised $300 million due to the fact that synthetic biology is so hot right now

Zymergen raised $300 million due to the fact that synthetic biology is so hot right now

Zymergen, one of the companies that’s developing biomanufacturing technologies that might reshape any variety of markets, stated it has actually raised $300 million in financing. It belongs to a wave of biotech business that TechCrunch covered in depth last month. Synthetic biology start-ups are providing investors a hunger The financial investment overall, announced yesterday, includes Series D […]…